Literature DB >> 20216158

Fundamentals of management of acute postoperative pulmonary hypertension.

Mary B Taylor1, Peter C Laussen.   

Abstract

In the last several years, there have been numerous advancements in the field of pulmonary hypertension as a whole, but there have been few changes in the management of children with pulmonary hypertension after cardiac surgery. Patients at particular risk for postoperative pulmonary hypertension can be identified preoperatively based on their cardiac disease and can be grouped into four broad categories based on the mechanisms responsible for pulmonary hypertension: 1) increased pulmonary vascular resistance; 2) increased pulmonary blood flow with normal pulmonary vascular resistance; 3) a combination of increased pulmonary vascular resistance and increased blood flow; and 4) increased pulmonary venous pressure. In this review of the immediate postoperative management of pulmonary hypertension, various strategies are discussed including medical therapies, monitoring, ventilatory strategies, and weaning from these supports. With early recognition of patients at particular risk for severe pulmonary hypertension, management strategies can be directed at preventing or minimizing hemodynamic instability and thereby prevent the development of ventricular dysfunction and a low output state.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20216158     DOI: 10.1097/PCC.0b013e3181c769a4

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  6 in total

1.  Long-Term Follow-Up of Pediatric Patients with Severe Postoperative Pulmonary Hypertension After Correction of Congenital Heart Defects.

Authors:  Lars Lindberg
Journal:  Pediatr Cardiol       Date:  2021-12-06       Impact factor: 1.655

2.  Effect of prostaglandin E1 inhalation on pulmonary hypertension following corrective surgery for congenital heart disease.

Authors:  Chun-Yan Zhang; Zeng-Shan Ma; Long-Le Ma; Le-Xin Wang
Journal:  Exp Clin Cardiol       Date:  2013

Review 3.  Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.

Authors:  Nathan Brunner; Vinicio A de Jesus Perez; Alice Richter; François Haddad; André Denault; Vanessa Rojas; Ke Yuan; Mark Orcholski; Xiaobo Liao
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

4.  Intrapulmonary shear stress enhancement: a new therapeutic approach in pulmonary arterial hypertension.

Authors:  Sayed Nour; Gang Dai; Daniel Carbognani; Minze Feng; Daya Yang; Nermine Lila; Juan Carlos Chachques; Guifu Wu
Journal:  Pediatr Cardiol       Date:  2012-05-06       Impact factor: 1.655

5.  Perioperative management of a patient with double orifice mitral valve with supramitral ring with subaortic membrane with ventricular septal defect and severe pulmonary hypertension: Report of a rare case.

Authors:  Vishnu Datt; Priyanka Khurana; Saket Aggarwal; Smita Mishra; C N Sujith; Sanjula Virmani
Journal:  Ann Card Anaesth       Date:  2019 Apr-Jun

6.  The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis.

Authors:  Tingting Shu; Huaqiao Chen; Lu Wang; Wuwan Wang; Panpan Feng; Rui Xiang; Li Wen; Wei Huang
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.